A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma
Wen-Tao Xiao, Si-Qi Wu, Ya-Rui Han, Jia-Hui Song, Jun-Yan He · 2026
Read A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma by Wen-Tao Xiao, Si-Qi Wu, Ya-Rui Han, Jia-Hui Song, Jun-Yan He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13357114.txt.
Description
Gullet cancer kills most patients, and a class of immune cells that usually calms inflammation may help the cancer grow, so their linked RNA markers might predict outlook. Wen-Tao Xiao and co-authors built such a marker set in this 2026 study. They used public tumor gene and clinical data for gullet cancer patients.
Long noncoding RNAs tied to those regulator B cells were combined into a risk signature. The signature was then related to survival, the immune landscape inside tumors, mutation patterns, and drug sensitivity. A validated signature could sort patients into risk groups for closer follow-up or stronger therapy. The authors present the work as a step toward immune-aware prognosis in a cancer where outlook tools are crude.
Catalog record
| CREATOR | Wen-Tao Xiao, Si-Qi Wu, Ya-Rui Han, Jia-Hui Song, Jun-Yan He |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |